Phase III Study of the Safety and Efficacy of Cl-108 in the Treatment of Moderate to Severe Pain
Clinical trial NCT01780428 · COMPLETED
Trial details
- NCT number
- NCT01780428
- Sponsor
- Charleston Laboratories, Inc
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-01-01
- Primary completion
- 2013-10-01
- Enrollment
- 460
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.